JP2016505026A5 - - Google Patents

Download PDF

Info

Publication number
JP2016505026A5
JP2016505026A5 JP2015553034A JP2015553034A JP2016505026A5 JP 2016505026 A5 JP2016505026 A5 JP 2016505026A5 JP 2015553034 A JP2015553034 A JP 2015553034A JP 2015553034 A JP2015553034 A JP 2015553034A JP 2016505026 A5 JP2016505026 A5 JP 2016505026A5
Authority
JP
Japan
Prior art keywords
granules
crystalline cellulose
gum
sugar
mesh screen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015553034A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016505026A (ja
JP6338598B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2014/000091 external-priority patent/WO2014111254A1/en
Publication of JP2016505026A publication Critical patent/JP2016505026A/ja
Publication of JP2016505026A5 publication Critical patent/JP2016505026A5/ja
Application granted granted Critical
Publication of JP6338598B2 publication Critical patent/JP6338598B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015553034A 2013-01-15 2014-01-14 チアクマイシン化合物の組成物 Active JP6338598B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13075002 2013-01-15
EP13075002.9 2013-01-15
PCT/EP2014/000091 WO2014111254A1 (en) 2013-01-15 2014-01-14 Composition of tiacumicin compounds

Publications (3)

Publication Number Publication Date
JP2016505026A JP2016505026A (ja) 2016-02-18
JP2016505026A5 true JP2016505026A5 (enExample) 2017-02-02
JP6338598B2 JP6338598B2 (ja) 2018-06-06

Family

ID=47563169

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015553034A Active JP6338598B2 (ja) 2013-01-15 2014-01-14 チアクマイシン化合物の組成物

Country Status (28)

Country Link
US (1) US9808530B2 (enExample)
EP (1) EP2945613B1 (enExample)
JP (1) JP6338598B2 (enExample)
KR (1) KR102181474B1 (enExample)
CN (1) CN105120840B (enExample)
AR (1) AR094495A1 (enExample)
AU (1) AU2014207083B2 (enExample)
CA (1) CA2904808A1 (enExample)
CY (1) CY1121459T1 (enExample)
DK (1) DK2945613T3 (enExample)
EA (1) EA030049B1 (enExample)
ES (1) ES2705238T3 (enExample)
GE (1) GEP201706769B (enExample)
HR (1) HRP20182110T1 (enExample)
HU (1) HUE041421T2 (enExample)
IL (1) IL239899A0 (enExample)
JO (1) JO3464B1 (enExample)
LT (1) LT2945613T (enExample)
MD (1) MD4588C1 (enExample)
NZ (1) NZ710875A (enExample)
PL (1) PL2945613T3 (enExample)
PT (1) PT2945613T (enExample)
RS (1) RS58119B1 (enExample)
SI (1) SI2945613T1 (enExample)
TW (1) TWI646962B (enExample)
UA (1) UA117004C2 (enExample)
WO (1) WO2014111254A1 (enExample)
ZA (1) ZA201505048B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3139932T3 (en) 2014-05-09 2018-11-12 Astellas Pharma Europe Ltd The treatment regimen for thiacumicin compound
CN110037992B (zh) * 2019-05-28 2021-05-28 杭州华东医药集团新药研究院有限公司 一种稳定的非达霉素组合物
CN116715678B (zh) * 2023-06-12 2025-09-30 中国科学院成都生物研究所 一种吲哚糖碳苷类大环化合物及其制备方法与应用

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3000792A (en) 1957-05-21 1961-09-19 Merck & Co Inc Antibiotic adsorption process
GB1458512A (en) 1973-11-22 1976-12-15 Lepetit Spa Antibiotic substance
US4632902A (en) 1981-08-20 1986-12-30 Becton, Dickinson And Company Method for detecting biological activity in a body fluid
US4918174A (en) 1986-09-26 1990-04-17 Abbott Laboratories Tiacumicin compounds
CA2050121C (en) 1991-03-04 2005-04-19 Glen A. Carey Automated analyzer
US5583115A (en) 1995-05-09 1996-12-10 Abbott Laboratories Dialkyltiacumicin compounds
US5767096A (en) 1996-07-12 1998-06-16 Abbott Laboratories Bromotiacumicin compounds
CN100344627C (zh) 1996-11-18 2007-10-24 生物技术研究有限公司(Gbf) 埃坡霉素c、其制备方法以及作为细胞抑制剂和植物保护剂的应用
JP2000072760A (ja) 1998-06-19 2000-03-07 Ajinomoto Co Inc 新規シストチアゾール類縁体
JP2000053514A (ja) 1998-08-06 2000-02-22 Aquas Corp レジオネラ属細菌が生産する殺菌性物質、これを用いた殺菌剤、水処理剤、スライム抑制剤、及びこれらの製造方法
JP2000239266A (ja) 1999-02-17 2000-09-05 Ajinomoto Co Inc 新規ポリエン系抗生物質
ATE309369T1 (de) 2000-04-28 2005-11-15 Kosan Biosciences Inc Heterologe herstellung von polyketiden
WO2002032427A1 (en) 2000-10-20 2002-04-25 Galephar M/F Stable oral formulation containing benzimidazole derivative
US20030099699A1 (en) 2001-11-13 2003-05-29 Hanshew Dwight D. Storage stable thyroxine active drug formulations and methods for their production
WO2004014295A2 (en) 2002-07-29 2004-02-19 Optimer Pharmaceuticals, Inc. Tiacumicin production
WO2006085838A1 (en) 2005-01-31 2006-08-17 Optimer Pharmaceuticals, Inc. 18-membered macrocycles and analogs thereof
US20070105791A1 (en) 2002-07-29 2007-05-10 Optimer Pharmaceuticals, Inc. Method of treating clostridium difficile-associated diarrhea
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US20080206161A1 (en) * 2002-10-25 2008-08-28 Dov Tamarkin Quiescent foamable compositions, steroids, kits and uses thereof
CA2510465A1 (en) 2002-12-18 2004-07-08 Pain Therapeutics Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats
WO2005009474A1 (ja) 2003-07-24 2005-02-03 Shionogi & Co., Ltd. 難水溶性薬物を含むドライシロップ剤
JP3881640B2 (ja) 2003-08-08 2007-02-14 塩野義製薬株式会社 ロラタジンを含むドライシロップ剤
US7906489B2 (en) 2004-05-14 2011-03-15 Optimer Pharmaceuticals, Inc. 18-membered macrocycles and analogs thereof
PL2070530T3 (pl) 2004-05-14 2016-06-30 Merck Sharp & Dohme Leczenie chorób związanych ze stosowaniem antybiotyków
US7378508B2 (en) 2007-01-22 2008-05-27 Optimer Pharmaceuticals, Inc. Polymorphic crystalline forms of tiacumicin B
US20110104267A1 (en) * 2005-04-25 2011-05-05 Aurobindo Pharma Limited Pharmaceutical compositions of antiretrovirals
EP1940417A4 (en) 2005-10-21 2010-07-07 Optimer Pharmaceuticals Inc METHOD FOR TREATING DIARRHOE IN CONNECTION WITH CLOSTRIDIUM DIFFICILE
US20080176927A1 (en) 2007-01-19 2008-07-24 Optimer Pharmaceuticals, Inc. Compositions of stable tiacumicins
ZA200905337B (en) 2007-01-22 2010-10-27 Optimer Pharmaceuticals Inc Macrocyclic polymorphs, compositions comprising such polymorphs, and methods of use and manufacture thereof
US8999395B2 (en) 2007-02-09 2015-04-07 Ceva Sante Animale Pharmaceutical compositions for oral administration in the form of stabilised aqueous suspensions
TWI523654B (zh) 2007-11-27 2016-03-01 默沙東藥廠 抗生素巨環化合物以及其製造及使用之方法
JP5608880B2 (ja) * 2010-02-09 2014-10-22 林兼産業株式会社 嚥下困難者用高栄養ゼリー食品
CN102030791B (zh) 2010-10-28 2013-01-23 中国科学院南海海洋研究所 四种台勾霉素类化合物及其制备方法和在制备抗菌药物中的应用
CN102115757B (zh) 2010-12-14 2015-10-28 中国科学院南海海洋研究所 台勾霉素的生物合成基因簇及其应用

Similar Documents

Publication Publication Date Title
CN103387365B (zh) 一种墙体砌筑保温砂浆
JP2009235073A5 (enExample)
SG190448A1 (en) Rapidly dispersing granules, orally disintegrating tablets and methods
DE602007002165D1 (de) Nuancierungsfarbstoffgranulat, seine verwendung inlung
BRPI0801794A2 (pt) processo para produção de fertilizante orgáno-mineral
RU2020119391A (ru) Получение тетрациклического соединения, содержащегося в высокой дозе
RU2016131243A (ru) Курительное изделие с материалом доставки жидкости
JP2016505026A5 (enExample)
JP2017078163A5 (enExample)
JP2016539949A5 (enExample)
JP2016073898A5 (enExample)
EA201590895A1 (ru) Битумная композиция в форме гранул и способ ее получения
JP2015523303A5 (enExample)
CN104396774B (zh) 一种添加多种吸水成分的混合型猫砂及其制备方法
JP2016108327A5 (enExample)
JP2019505549A5 (enExample)
CA2796541A1 (en) Lozenges of erythritol and isomalt
JP2015231600A5 (enExample)
JP2013142155A5 (enExample)
CN102690361A (zh) 一种具有吸附缓释能力的糯米变性淀粉的制备方法
RU2007135607A (ru) Способ приготовления белково-углеводного продукта
JP2016053063A5 (enExample)
WO2018069804A3 (en) New furazidin compositions and methods of their manufacture
RU2012145868A (ru) Высушенный распылительной сушкой кристаллический активный ингредиент
RU2015110460A (ru) Способ получения сахарсодержащего продукта